These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2216954)

  • 1. [Interactions of antineoplastic agents with other drugs].
    Drzewoski J; Robak T
    Pol Tyg Lek; 1990 Feb 5-12; 45(6-7):145-8. PubMed ID: 2216954
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase 1 first-in-human clinical study of S-trans,trans-farnesylthiosalicylic acid (salirasib) in patients with solid tumors.
    Tsimberidou AM; Rudek MA; Hong D; Ng CS; Blair J; Goldsweig H; Kurzrock R
    Cancer Chemother Pharmacol; 2010 Jan; 65(2):235-41. PubMed ID: 19484470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and Pharmacokinetics of Anti-Cancer Drugs.
    Desai PB; Sane RS
    Toxicol In Vitro; 2006 Mar; 20(2):133-4. PubMed ID: 16321499
    [No Abstract]   [Full Text] [Related]  

  • 4. New derivatives of farnesylthiosalicylic acid (salirasib) for cancer treatment: farnesylthiosalicylamide inhibits tumor growth in nude mice models.
    Goldberg L; Haklai R; Bauer V; Heiss A; Kloog Y
    J Med Chem; 2009 Jan; 52(1):197-205. PubMed ID: 19072665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose edatrexate with oral leucovorin rescue: a phase I and clinical pharmacological study in adults with advanced cancer.
    Pisters KM; Tyson LB; Tong W; Fleisher M; Miller VA; Grant SC; Pfister DG; Rigas JR; Densmore CL; Krol G; Heelan RT; Sirotnak FM; Bertino JR; Kris MG
    Clin Cancer Res; 1996 Nov; 2(11):1819-24. PubMed ID: 9816135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of high-dose methotrexate with thymidine and low-dose leucovorin.
    Bruno S; Grindey G; Zakrzewski S; Priore R; Kinahan J; Moayeri H; Ledesma E; Mittelman A; Creaven P
    Cancer Res; 1982 Nov; 42(11):4824-6. PubMed ID: 6982097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug interactions with vitamin K antagonists].
    Thebault J; Tillement JP; Blatrix C
    Pathol Biol (Paris); 1973 Jun; 21(6):639-46. PubMed ID: 4581196
    [No Abstract]   [Full Text] [Related]  

  • 8. Podophyllin-salicylic acid solution in treatment of basal cell carcinomas.
    Nelson LM
    Arch Dermatol; 1966 Apr; 93(4):457-9. PubMed ID: 5862640
    [No Abstract]   [Full Text] [Related]  

  • 9. [The interactions of antiepileptic drugs in oncology practice].
    Armijo JA; Sánchez MB; Campos C; Adín J
    Rev Neurol; 2006 Jun 1-15; 42(11):681-90. PubMed ID: 16736404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential drug interactions and duplicate prescriptions among cancer patients.
    Riechelmann RP; Tannock IF; Wang L; Saad ED; Taback NA; Krzyzanowska MK
    J Natl Cancer Inst; 2007 Apr; 99(8):592-600. PubMed ID: 17440160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs for treatment of peptic ulcers.
    Med Lett Drugs Ther; 1997 Jan; 39(991):1-4. PubMed ID: 8996458
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug interactions with anticancer agents].
    Furue H
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2231-6. PubMed ID: 3907502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics in the elderly.
    Lichtman SM
    Clin Adv Hematol Oncol; 2007 Mar; 5(3):181-2. PubMed ID: 17519878
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent advances in cancer chemotherapy: current strategies, pharmacokinetics, and pharmacogenomics.
    Nishiyama M; Eguchi H
    Adv Drug Deliv Rev; 2009 May; 61(5):367-8. PubMed ID: 19154764
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical application of the thymidine incorporation assay.
    Kern DH; Sondak VK; Morgan CR; Hildebrand-Zanki SU
    Ann Clin Lab Sci; 1987; 17(6):383-8. PubMed ID: 3688821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular imaging as a tool for personalized and targeted anticancer therapy.
    McLarty K; Reilly RM
    Clin Pharmacol Ther; 2007 Mar; 81(3):420-4. PubMed ID: 17339871
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticancer drugs: pharmacology and drug interactions.
    Tattersall MH
    Clin Oncol; 1975 Sep; 1(3):223-33. PubMed ID: 1212830
    [No Abstract]   [Full Text] [Related]  

  • 18. [Locacorten preparations in treating some skin diseases].
    Smelov NS; Trofimova LIa; Mordovtsev VN; Makovoz VI
    Sov Med; 1971; 34(12):91-4. PubMed ID: 4260227
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological modulation of 5-fluorouracil and its clinical implications: an overview.
    Gebbia V; Testa A; Borsellino N; Cannata G; Valenza R; Gebbia N
    In Vivo; 1993; 7(6B):639-44. PubMed ID: 8193287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiphlogistic effect of salicylic acid and its derivatives].
    Binder M; Zeiller P
    Fortschr Med; 1993 Nov; 111(33):530-2. PubMed ID: 8307537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.